의료기기 안전성 정보 안내[정형용품 회수]
1. 관련 근거: 식품의약품안전처 의료기기안전평가과-1499(2020.3.16.)
2. 독일 연방의약품의료기기연구원(BfArM)에서 Zimmer Biomet社의 ‘정형용품'이 제조과정에서 세척이
효과적으로 되지 않았을 가능성이 있어 회수를 실시한다고 공지('20.3.16)하였습니다.
* 인공관절 등 시술 후 2차 감염이 생겼을 경우, 감염을 치료하기 위해 인공 관절 등을 제거하고 제거된
빈 공간에 시멘트를 주입할 때 쓰이는 틀
** 정보출처: https://www.bfarm.de/SharedDocs/Kundeninfos/EN/11/2020/03506-20_kundeninfo_en.pdf?__blob=publicationFile&v=1
3. 이에 정형용품(회수업체:(유) 짐머바이오메트코리아, 제품명: StageOne and StageOne Select Bone
Cement Spacer Molds, 상세 정보 붙임1참조)를 보유하고 있는 경우, 사용을 즉시 중지하고 회수업체
에서 회수가 적절히 이루어지도록 협조하여 주시기 바랍니다.
4. 아울러, 의료기기 부작용 등 이상사례를 인지하는 경우에는 식품의약품안전처 홈페이지(https://emed.
mfds.go.kr → 보고마당 → 이상사례보고) 또는 유선(의료기기안전평가과: 043-719-5007, 5015)으로
알려주시기 바랍니다.
붙임 1. 대상제품 정보
ZIMMER BIOMET
March 10, 2020
To: Hospital
Subject: URGENT MEDICAL DEVICE FIELD SAFETY NOTICE - REMOVAL
Reference: ZFA2020-00026
Affected Product: StageOne™ and StageOne™ Select Bone Cement Spacer Molds
All lots expiring prior to February 28, 2030 | |||
Item Number | Description | Item Number | Description |
431107 | StageOne Hip Cement Spacer Mold, 9 X 125 MM, 43 MM | 431207 | StageOne Hip Cement Spacer Mold with Reinforcement, 9 X 125 MM, 43 MM |
431109 | StageOne Hip Cement Spacer Mold, 9 X 125 MM, 51 MM | 431209 | StageOne Hip Cement Spacer Mold with Reinforcement, 9 X 125 MM, 51 MM |
431113 | StageOne Hip Cement Spacer Mold, 13 X 145 MM, 57 MM | 431213 | StageOne Hip Cement Spacer Mold with Reinforcement, 13 X 145 MM, 57 MM |
431117 | StageOne Hip Cement Spacer Mold, 17 X 165 MM, 64 MM | 431217 | StageOne Hip Cement Spacer Mold with Reinforcement, 17 X 165 MM, 64 MM |
431181 | StageOne Select Hip Head Cement Spacer Mold with Insert, 48 MM | 431406 | StageOne Shoulder Cement Spacer Mold, 6 MM, 42 X 18 X 46 MM, Standard |
431182 | StageOne Select Hip Head Cement Spacer Mold with Insert, 52 MM | 431408 | StageOne Shoulder Cement Spacer Mold, 8 MM, 46 X 18 X 53 MM, Standard |
431183 | StageOne Select Hip Head Cement Spacer Mold with Insert, 56 MM | 431410 | StageOne Shoulder Cement Spacer Mold, 10 MM, 50 X 21 X 57 MM, Standard |
431184 | StageOne Select Hip Head Cement Spacer Mold with Insert, 60 MM | 431412 | StageOne Shoulder Cement Spacer Mold, 12MM, 54 X 21 X 64 MM, Standard |
431185 | StageOne Select Hip Head Cement Spacer Mold with Insert, 64 MM | 431414 | StageOne Shoulder Cement Spacer Mold, 14 MM, 58 X 24 X 64 MM, Standard |
431190 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 9 X 125 MM | 432160 | StageOne Knee Femoral Cement Spacer Mold, 60 MM |
431191 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 11 X 135 MM | 432165 | StageOne Knee Femoral Cement Spacer Mold, 65 MM |
431192 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 13 X 145 MM | 432170 | StageOne Knee Femoral Cement Spacer Mold, 70 MM |
431193 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 15 X 155 MM | 432175 | StageOne Knee Femoral Cement Spacer Mold, 75 MM |
431194 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 17 X 165 MM | 433165 | StageOne Knee Tibial Cement Spacer Mold, 65 MM |
431195 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 9 X 200 MM | 433170 | StageOne Knee Tibial Cement Spacer Mold, 70 MM |
431196 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 11 X 200 MM | 433175 | StageOne Knee Tibial Cement Spacer Mold, 75 MM |
431197 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 13 X 200 MM | 433180 | StageOne Knee Tibial Cement Spacer Mold, 80 MM |
431198 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 15 X 200 MM | cp161972 | StageOne Custom Hip Femoral Reinforcement, 9 X 125 MM |
431199 | StageOne Select Hip Stem Cement Spacer Mold with Reinforcement, 17 X 200 MM |
|
As a precautionary measure Zimmer Orthopedics is conducting a medical device Field Safety Corrective Action (removal) for StageOne™ and StageOne™ Select Bone Cement Spacer Molds. Certain devices
may have been subject to a potentially insufficient cleaning process or to potentially inadequate process monitoring for cleaning parameters. For the more than 230,000 devices distributed, to date there have
been five complaints for events which may be associated with this issue.
These devices are a single-use silicone mold intended to be filled with bone cement. Upon curing of the bone cement, a temporary bone cement spacer is created for patients undergoing a two-stage revision
due to infection. The resulting bone cement spacer typically remains in place for less than six months
with partial weight bearing until the second stage of the two-stage revision is performed to implant a
conventional prosthesis.
Risks | ||
Describe immediate health consequences (injuries or illness) that may result from use of or exposure to the product issue. | Most Probable | Highest Severity |
None | None | |
Describe long range health consequences (injuries or illness) that may result from use of or exposure to the product issue. | Most Probable | Highest Severity |
None | Adverse Local Tissue Reaction, Pain or Ache (critical), Reaction to Allergen or Toxin (severe systemic) |
Our records indicate that you may have received one or more of the potentially affected products. The
potentially affected units were distributed between January 2009 and January 2020. (Local deployment
may differ).
Hospital Responsibilities:
1. Review this Field Safety Notice and ensure that affected personnel are aware of the contents.
2. If you have any potentially affected implants at your facility, assist your Zimmer Biomet sales
representative and quarantine all potentially affected implants. Your Zimmer Biomet sales
representative will remove the potentially affected implants from your facility.
3. Complete Attachment 1 – Certificate of Acknowledgement and send to
fieldaction.bridgend@zimmerbiomet.com. This form must be returned even if you do not have
potentially affected implants at your facility.
4. Retain a copy of the acknowledgement form with your field action records in the event of a
compliance audit of your facility’s documentation.
5. If you have further questions or concerns after reviewing this Field Safety Notice, please contact
your Zimmer Biomet representative.
Surgeon Responsibilities:
1. Review this notification for awareness of the contents.
2. There are no specific patient monitoring instructions related to this recall that are recommended
beyond your existing follow-up schedule. The potential long term risks would likely occur within
one year of beginning the two-stage revision.
3. Complete Attachment 1 – Certificate of Acknowledgement and send to
fieldaction.bridgend@zimmerbiomet.com. This form must be returned even if you do not have
potentially affected implants at your facility.
4. Retain a copy of the acknowledgement form with your recall records in the event of a compliance
audit of your facility’s documentation.
5. If you have further questions or concerns after reviewing this Field Safety Notice, please contact
your Zimmer Biomet representative.
Other Information
This medical device Field Safety Notice was reported to all relevant Competent Authorities and the related Notified Body as required under the applicable regulations for Medical Devices as per MEDDEV 2.12-1 in Europe.
Please keep Zimmer Biomet informed of any adverse events associated with this units or any other Zimmer Biomet product by emailing winterthur.per@zimmerbiomet.com or to your local Zimmer Biomet contact.
Please be aware that the names of user facilities notified are routinely provided to the Competent Authorities for audit purposes. The undersigned confirms that this notice has been delivered to the appropriate Regulatory Agencies.
We would like to thank you for your co-operation in advance and regret any inconveniences caused by
this field action.
Sincerely,
ATTACHMENT 1 fieldaction.bridgend@zimmerbiomet.com returned:
OR Printed Name: _____________________ Signature: ____________________________ Date:____/____/____ |
'식약청.의약 안전성,허가사항관련' 카테고리의 다른 글
의약품 안전성 서한 안내(울리프리스탈 성분제제) 2020.4.14 (0) | 2020.04.14 |
---|---|
「마약류 취급보고 제도」 온라인 교육(마약류취급자대상) 안내2020.4.8 (0) | 2020.04.09 |
2019년 의약품 부작용 보고 동향 분석 2020.3.16 (0) | 2020.03.16 |
의료기기 안전성 정보 안내[전기사용 의료기기] 2020.3.11 (0) | 2020.03.12 |
의약품 안전성 서한 안내(로카세린 성분제제)2020.2.14 식약처 (0) | 2020.02.19 |